← 返回

推进针对癌症的 NK 细胞疗法

英文原题:Advancing natural killer therapies against cancer.

查看英文原题

Advancing natural killer therapies against cancer.

PubMed 2022/04/28(内容时间) Cell Q1 · IF 45.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

基于NK细胞的抗癌疗法正在兴起,但要优化这些治疗,仍需完善对NK细胞功能的理解。在本期,Pan等人(2022)表明,促凋亡分子(如BH3模拟物)与NK细胞协同作用,诱导肿瘤细胞中线粒体驱动的凋亡,从而增强NK细胞疗法的疗效。

展开英文摘要原文

Natural killer (NK)-based therapies against cancer are emerging, but the understanding of NK cell functions needs to be completed to optimize these treatments. In this issue, Pan et al. (2022) show that pro-apoptotic molecules, such as BH3-mimetics, synergize with NK cells to induce mitochondria-driven apoptosis in tumor cells, thereby enhancing the efficacy of NK cell therapies.

论文信息

作者
Narni-Mancinelli E、Vivier E
单位
Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France. Electronic address: narni@ciml.univ-mrs.fr.France
文献类型
非美国政府资助研究 · 评论
期刊
Cell2022 Apr 28
原文标识
PubMed 35487189 · DOI 10.1016/j.cell.2022.04.006